Insider Trading › IONS › Insiders
IONIS PHARMACEUTICALS INC
IONS·Nasdaq·
United States·Insider activity
United States·Insider activity$44.16
+0.16 (+0.36%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
IONS
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
IONSS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, IONS insiders filed 2 purchases ($1.1M) and 29 sales ($27.9M) on the open market, by 15 insiders. Newest filing Jul 31, 2026 (2 months ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by IONS insiders · Form 4 · last two years
On Record
$1.1MPurchases · 180 days
$27.9MSales · 180 days
707Open-market transactions on record
15Insiders filing · 180 days
Purchases (code P) and sales (code S) of IONS common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
707 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Hayden Michael RDirector · Director | Purchase | +5,000 | $51.60 | $258K | 24.0Kindirect | Jul 31, 2026 | Jul 31, 2026 | Form 4 ↗ |
| Hayden Michael RDirector · Director | Purchase | +15.0K | $53.38 | $801K | 19.0Kindirect | Jul 30, 2026 | Jul 31, 2026 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −5,536 | $83.58 | $463K | 75.0Kdirect | Jul 7, 2026 | Jul 9, 2026 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −15.0K | $85.46 | $1.3M | 0indirect | Jul 7, 2026 | Jul 9, 2026 | Form 4 ↗ |
| Diaz Allene M.Director · Director | Sale | −10.1K | $85.42 | $864K | 3,811direct | Jul 7, 2026 | Jul 9, 2026 | Form 4 ↗ |
| Kordasiewicz Holly B.EVP, Chief Development Officer | Sale | −362 | $84.30 | $31K | 22.1Kdirect | Jul 7, 2026 | Jul 9, 2026 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector · Director | Sale | −99 | $79.45 | $8K | 22.4Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector · Director | Sale | −11.4K | $79.04 | $903K | 11.0Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −5,635 | $80.16 | $452K | 4,669indirect | Jun 26, 2026 | Jun 30, 2026 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −3,069 | $80.00 | $246K | 61.5Kdirect | Jun 26, 2026 | Jun 30, 2026 | Form 4 ↗ |
| Schneider EugeneEVP, Chf Clinical Develop Ofcr | Sale | −26.0K | $81.05 | $2.1M | 77.1Kdirect | Jun 26, 2026 | Jun 30, 2026 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −50.0K | $80.59 | $4.0M | 245.6Kdirect | Jun 26, 2026 | Jun 26, 2026 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −21.1K | $78.49 | $1.7M | 245.6Kdirect | Jun 25, 2026 | Jun 26, 2026 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −10.6K | $79.18 | $839K | 21.8Kdirect | Jun 25, 2026 | Jun 26, 2026 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −14.6K | $78.41 | $1.1M | 245.6Kdirect | Jun 24, 2026 | Jun 26, 2026 | Form 4 ↗ |
| BERTHELSEN SPENCER RDirector | Sale | −8,000 | $73.49 | $588K | 156.0Kdirect | Jun 15, 2026 | Jun 16, 2026 | Form 4 ↗ |
| Kordasiewicz Holly B.EVP, Chief Development Officer | Sale | −19.8K | $74.05 | $1.5M | 22.5Kdirect | Jun 12, 2026 | Jun 16, 2026 | Form 4 ↗ |
| Kordasiewicz Holly B.EVP, Chief Development Officer | Sale | −41.0K | $73.09 | $3.0M | 42.3Kdirect | Jun 12, 2026 | Jun 16, 2026 | Form 4 ↗ |
| BERTHELSEN SPENCER RDirector | Sale | −8,000 | $75.67 | $605K | 156.0Kdirect | Jun 1, 2026 | Jun 3, 2026 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −3,220 | $78.68 | $253K | 242.7Kdirect | May 14, 2026 | May 15, 2026 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −1,316 | $78.01 | $103K | 242.7Kdirect | May 13, 2026 | May 15, 2026 | Form 4 ↗ |
| LOSCALZO JOSEPHDirector | Sale | −17.8K | $75.58 | $1.3M | 36.3Kdirect | May 4, 2026 | May 6, 2026 | Form 4 ↗ |
| LOSCALZO JOSEPHDirector | Sale | −59.5K | $74.90 | $4.5M | 54.1Kdirect | May 4, 2026 | May 6, 2026 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −1,431 | $74.45 | $107K | 11.0Kdirect | May 1, 2026 | May 5, 2026 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −8,680 | $73.35 | $637K | 12.4Kdirect | May 1, 2026 | May 5, 2026 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −1,626 | $71.79 | $117K | 44.9Kdirect | Apr 28, 2026 | Apr 30, 2026 | Form 4 ↗ |
| Jenne KyleEVP, Chf GL Pdt Str Ofcr | Sale | −4,902 | $75.17 | $368K | 23.7Kdirect | Apr 16, 2026 | Apr 17, 2026 | Form 4 ↗ |
| Birchler BrianEVP, Corp and Development Ops | Sale | −973 | $75.04 | $73K | 67.5Kdirect | Apr 16, 2026 | Apr 17, 2026 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −5,619 | $74.56 | $419K | 46.5Kdirect | Apr 16, 2026 | Apr 17, 2026 | Form 4 ↗ |
| PARSHALL B LYNNEDirector | Sale | −534 | $76.97 | $41K | 51.3Kdirect | Apr 15, 2026 | Apr 17, 2026 | Form 4 ↗ |
| PARSHALL B LYNNEDirector | Sale | −4,466 | $76.19 | $340K | 51.9Kdirect | Apr 15, 2026 | Apr 17, 2026 | Form 4 ↗ |
| Devers Shannon L.EVP, Chief Human Resources Ofc | Sale | −6,193 | $74.05 | $459K | 16.3Kdirect | Apr 2, 2026 | Apr 2, 2026 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −2,216 | $75.95 | $168K | 11.0Kdirect | Apr 1, 2026 | Apr 2, 2026 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −20.1K | $75.50 | $1.5M | 13.2Kdirect | Apr 1, 2026 | Apr 2, 2026 | Form 4 ↗ |
| Schneider EugeneEVP, Chf Clinical Develop Ofcr | Sale | −5,812 | $70.97 | $412K | 63.9Kdirect | Mar 19, 2026 | Mar 23, 2026 | Form 4 ↗ |
| HOUGEN ELIZABETH LEVP, Finance & CFO | Sale | −10.2K | $73.21 | $745K | 82.7Kdirect | Mar 17, 2026 | Mar 18, 2026 | Form 4 ↗ |
| HOUGEN ELIZABETH LEVP, Finance & CFO | Sale | −9,440 | $72.77 | $687K | 92.8Kdirect | Mar 16, 2026 | Mar 18, 2026 | Form 4 ↗ |
| HOUGEN ELIZABETH LEVP, Finance & CFO | Sale | −205.6K | $72.38 | $14.9M | 102.3Kdirect | Mar 16, 2026 | Mar 18, 2026 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −17.6K | $76.34 | $1.3M | 242.7Kdirect | Mar 10, 2026 | Mar 11, 2026 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −16.5K | $75.47 | $1.2M | 260.3Kdirect | Mar 10, 2026 | Mar 11, 2026 | Form 4 ↗ |
| Jenne KyleEVP, Chf GL Pdt Str Ofcr | Sale | −16.1K | $76.30 | $1.2M | 11.7Kdirect | Mar 10, 2026 | Mar 11, 2026 | Form 4 ↗ |
| Jenne KyleEVP, Chf GL Pdt Str Ofcr | Sale | −21.2K | $75.50 | $1.6M | 27.8Kdirect | Mar 10, 2026 | Mar 11, 2026 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −10.1K | $75.25 | $764K | 62.2Kdirect | Mar 9, 2026 | Mar 11, 2026 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −1,684 | $75.58 | $127K | 242.7Kdirect | Mar 9, 2026 | Mar 11, 2026 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −117.6K | $75.26 | $8.9M | 244.3Kdirect | Mar 9, 2026 | Mar 11, 2026 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −7,382 | $74.11 | $547K | 361.9Kdirect | Mar 9, 2026 | Mar 11, 2026 | Form 4 ↗ |
| LOSCALZO JOSEPHDirector | Sale | −200 | $80.00 | $16K | 36.3Kdirect | Mar 4, 2026 | Mar 5, 2026 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −201 | $80.00 | $16K | 4,347indirect | Mar 4, 2026 | Mar 5, 2026 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −238 | $80.00 | $19K | 4,347indirect | Mar 4, 2026 | Mar 5, 2026 | Form 4 ↗ |
| LOSCALZO JOSEPHDirector | Sale | −832 | $80.33 | $67K | 36.3Kdirect | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −1,012 | $80.82 | $82K | 11.0Kdirect | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −6,794 | $80.00 | $544K | 12.0Kdirect | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −13.5K | $79.17 | $1.1M | 18.8Kdirect | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| Diaz Allene M.Director | Sale | −1,005 | $80.80 | $81K | 3,811direct | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| Diaz Allene M.Director | Sale | −14.6K | $79.88 | $1.2M | 4,816direct | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| Diaz Allene M.Director | Sale | −39.3K | $79.11 | $3.1M | 19.4Kdirect | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| Devers Shannon L.EVP, Chief Human Resources Ofc | Sale | −755 | $80.84 | $61K | 22.5Kdirect | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| Devers Shannon L.EVP, Chief Human Resources Ofc | Sale | −5,030 | $80.00 | $402K | 23.3Kdirect | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| Devers Shannon L.EVP, Chief Human Resources Ofc | Sale | −14.3K | $79.12 | $1.1M | 28.3Kdirect | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −802 | $80.76 | $65K | 80.6Kdirect | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −12.7K | $79.88 | $1.0M | 81.4Kdirect | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −71.6K | $79.10 | $5.7M | 94.0Kdirect | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −36 | $81.01 | $3K | 4,347indirect | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −2,088 | $80.41 | $168K | 4,383indirect | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −4,096 | $79.36 | $325K | 41.3Kdirect | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −6,207 | $82.07 | $509K | 32.1Kdirect | Feb 13, 2026 | Feb 13, 2026 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −9,435 | $81.56 | $770K | 38.3Kdirect | Feb 13, 2026 | Feb 13, 2026 | Form 4 ↗ |
| PARSHALL B LYNNEDirector | Sale | −5,000 | $82.72 | $414K | 56.3Kdirect | Feb 11, 2026 | Feb 13, 2026 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −29.4K | $85.79 | $2.5M | 254.5Kdirect | Feb 6, 2026 | Feb 10, 2026 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −16.5K | $83.03 | $1.4M | 80.3Kdirect | Feb 2, 2026 | Feb 4, 2026 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −48.6K | $83.03 | $4.0M | 80.3Kdirect | Feb 2, 2026 | Feb 4, 2026 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −20.0K | $82.60 | $1.7M | 80.3Kdirect | Feb 2, 2026 | Feb 4, 2026 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −6,179 | $82.93 | $512K | 47.7Kdirect | Jan 30, 2026 | Feb 2, 2026 | Form 4 ↗ |
| Schneider EugeneEVP, Chf Clinical Develop Ofcr | Sale | −6,179 | $83.45 | $516K | 69.7Kdirect | Jan 30, 2026 | Feb 2, 2026 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −6,179 | $83.53 | $516K | 72.0Kdirect | Jan 30, 2026 | Feb 2, 2026 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −63.0K | $82.72 | $5.2M | 283.9Kdirect | Jan 30, 2026 | Feb 2, 2026 | Form 4 ↗ |
| HOUGEN ELIZABETH LEVP, Finance & CFO | Sale | −6,988 | $83.24 | $582K | 132.9Kdirect | Jan 30, 2026 | Feb 2, 2026 | Form 4 ↗ |
| Birchler BrianEVP, Corp and Development Ops | Sale | −6,179 | $83.03 | $513K | 66.2Kdirect | Jan 30, 2026 | Feb 2, 2026 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −5,885 | $82.95 | $488K | 100.3Kdirect | Jan 30, 2026 | Feb 2, 2026 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −5,296 | $82.96 | $439K | 45.4Kdirect | Jan 30, 2026 | Feb 2, 2026 | Form 4 ↗ |
| Devers Shannon L.EVP, Chief Human Resources Ofc | Sale | −3,977 | $81.34 | $323K | 22.5Kdirect | Jan 22, 2026 | Jan 23, 2026 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −49 | $75.97 | $4K | 318indirect | Jan 16, 2026 | Jan 20, 2026 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −9,884 | $75.34 | $745K | 41.9Kdirect | Jan 16, 2026 | Jan 20, 2026 | Form 4 ↗ |
| Schneider EugeneEVP, Chf Clinical Develop Ofcr | Sale | −9,302 | $75.59 | $703K | 63.9Kdirect | Jan 16, 2026 | Jan 20, 2026 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −9,191 | $75.84 | $697K | 66.2Kdirect | Jan 16, 2026 | Jan 20, 2026 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −44.0K | $74.82 | $3.3M | 224.7Kdirect | Jan 16, 2026 | Jan 20, 2026 | Form 4 ↗ |
| Kordasiewicz Holly B.EVP, Chief Development Officer | Sale | −4,141 | $75.66 | $313K | 14.7Kdirect | Jan 16, 2026 | Jan 20, 2026 | Form 4 ↗ |
| Jenne KyleEVP, Chf GL Pdt Str Ofcr | Sale | −1,823 | $75.96 | $138K | 16.4Kdirect | Jan 16, 2026 | Jan 20, 2026 | Form 4 ↗ |
| HOUGEN ELIZABETH LEVP, Finance & CFO | Sale | −12.9K | $75.22 | $972K | 126.3Kdirect | Jan 16, 2026 | Jan 20, 2026 | Form 4 ↗ |
| Devers Shannon L.EVP, Chief Human Resources Ofc | Sale | −8,353 | $75.95 | $634K | 26.5Kdirect | Jan 16, 2026 | Jan 20, 2026 | Form 4 ↗ |
| Birchler BrianEVP, Corp and Development Ops | Sale | −8,480 | $75.11 | $637K | 60.4Kdirect | Jan 16, 2026 | Jan 20, 2026 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −8,977 | $75.15 | $675K | 94.8Kdirect | Jan 16, 2026 | Jan 20, 2026 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −1,149 | $75.78 | $87K | 4,772indirect | Jan 16, 2026 | Jan 20, 2026 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −6,907 | $75.75 | $523K | 40.4Kdirect | Jan 16, 2026 | Jan 20, 2026 | Form 4 ↗ |
| Devers Shannon L.EVP, Chief Human Resources Ofc | Sale | −9,264 | $84.62 | $784K | 17.5Kdirect | Jan 7, 2026 | Jan 9, 2026 | Form 4 ↗ |
| Devers Shannon L.EVP, Chief Human Resources Ofc | Sale | −3,829 | $84.62 | $324K | 17.5Kdirect | Jan 7, 2026 | Jan 9, 2026 | Form 4 ↗ |
| Devers Shannon L.EVP, Chief Human Resources Ofc | Sale | −3,460 | $84.62 | $293K | 17.5Kdirect | Jan 7, 2026 | Jan 9, 2026 | Form 4 ↗ |
| Devers Shannon L.EVP, Chief Human Resources Ofc | Sale | −2,101 | $85.36 | $179K | 17.5Kdirect | Jan 7, 2026 | Jan 9, 2026 | Form 4 ↗ |
| Devers Shannon L.EVP, Chief Human Resources Ofc | Sale | −25.5K | $85.36 | $2.2M | 17.5Kdirect | Jan 7, 2026 | Jan 9, 2026 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −18.3K | $79.27 | $1.5M | 30.5Kdirect | Jan 2, 2026 | Jan 6, 2026 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −5,125 | $78.57 | $403K | 30.5Kdirect | Jan 2, 2026 | Jan 6, 2026 | Form 4 ↗ |
| WENDER JOSEPH HDirector | Sale | −7,429 | $81.23 | $603K | 36.0Kindirect | Dec 1, 2025 | Dec 3, 2025 | Form 4 ↗ |
| WENDER JOSEPH HDirector | Sale | −20.6K | $80.67 | $1.7M | 43.5Kindirect | Dec 1, 2025 | Dec 3, 2025 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −4,000 | $80.00 | $320K | 0indirect | Nov 25, 2025 | Nov 28, 2025 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −4,000 | $80.00 | $320K | 0indirect | Nov 25, 2025 | Nov 28, 2025 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −4,000 | $80.00 | $320K | 0indirect | Nov 25, 2025 | Nov 28, 2025 | Form 4 ↗ |
| Devers Shannon L.EVP, Chief Human Resources Ofc | Sale | −16.8K | $80.91 | $1.4M | 17.5Kdirect | Nov 25, 2025 | Nov 28, 2025 | Form 4 ↗ |
| HERMAN JOAN EDirector | Sale | −32.0K | $72.13 | $2.3M | 46.1Kdirect | Nov 19, 2025 | Nov 20, 2025 | Form 4 ↗ |
| HERMAN JOAN EDirector | Sale | −12.0K | $72.13 | $866K | 46.1Kdirect | Nov 19, 2025 | Nov 20, 2025 | Form 4 ↗ |
| Birchler BrianEVP, Corp and Development Ops | Sale | −8,000 | $76.17 | $609K | 48.8Kdirect | Nov 6, 2025 | Nov 7, 2025 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −18.3K | $75.42 | $1.4M | 59.7Kdirect | Nov 6, 2025 | Nov 7, 2025 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −14.7K | $76.10 | $1.1M | 59.7Kdirect | Nov 6, 2025 | Nov 7, 2025 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −801 | $75.01 | $60K | 59.7Kdirect | Nov 5, 2025 | Nov 7, 2025 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −800 | $75.01 | $60K | 59.7Kdirect | Nov 5, 2025 | Nov 7, 2025 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale Amended | −905 | $75.05 | $68K | 59.7Kdirect | Nov 3, 2025 | Nov 7, 2025 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale Amended | −775 | $75.05 | $58K | 59.7Kdirect | Nov 3, 2025 | Nov 7, 2025 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −905 | $75.05 | $68K | 59.7Kdirect | Nov 3, 2025 | Nov 3, 2025 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −775 | $75.05 | $58K | 59.7Kdirect | Nov 3, 2025 | Nov 3, 2025 | Form 4 ↗ |
| WENDER JOSEPH HDirector | Sale | −11.2K | $75.16 | $842K | 64.0Kindirect | Oct 31, 2025 | Nov 3, 2025 | Form 4 ↗ |
| LOSCALZO JOSEPHDirector | Sale | −16.0K | $75.10 | $1.2M | 36.3Kdirect | Oct 31, 2025 | Nov 3, 2025 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −20.0K | $75.11 | $1.5M | 59.7Kdirect | Oct 31, 2025 | Nov 3, 2025 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −34.7K | $75.11 | $2.6M | 79.7Kdirect | Oct 31, 2025 | Nov 3, 2025 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −34.6K | $75.11 | $2.6M | 79.7Kdirect | Oct 31, 2025 | Nov 3, 2025 | Form 4 ↗ |
| WENDER JOSEPH HDirector | Sale | −5,975 | $73.85 | $441K | 75.2Kindirect | Oct 30, 2025 | Nov 3, 2025 | Form 4 ↗ |
| WENDER JOSEPH HDirector | Sale | −8,341 | $73.16 | $610K | 81.2Kindirect | Oct 30, 2025 | Nov 3, 2025 | Form 4 ↗ |
| WENDER JOSEPH HDirector | Sale | −2,484 | $72.19 | $179K | 89.6Kindirect | Oct 30, 2025 | Nov 3, 2025 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −53 | $73.62 | $4K | 256indirect | Oct 16, 2025 | Oct 16, 2025 | Form 4 ↗ |
| Devers Shannon L.EVP, Chief Human Resources Ofc | Sale | −1,263 | $73.62 | $93K | 17.5Kdirect | Oct 16, 2025 | Oct 16, 2025 | Form 4 ↗ |
| PARSHALL B LYNNEDirector | Sale | −5,000 | $71.74 | $359K | 61.3Kdirect | Oct 15, 2025 | Oct 16, 2025 | Form 4 ↗ |
| Devers Shannon L.EVP, Chief Human Resources Ofc | Sale | −6,000 | $72.94 | $438K | 15.9Kdirect | Oct 15, 2025 | Oct 16, 2025 | Form 4 ↗ |
| Birchler BrianEVP, Corp and Development Ops | Sale | −12.4K | $72.23 | $897K | 56.8Kdirect | Oct 15, 2025 | Oct 16, 2025 | Form 4 ↗ |
| Birchler BrianEVP, Corp and Development Ops | Sale | −11.5K | $72.03 | $827K | 56.8Kdirect | Oct 14, 2025 | Oct 16, 2025 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −6,849 | $69.02 | $473K | 30.5Kdirect | Oct 6, 2025 | Oct 8, 2025 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −3,241 | $69.27 | $225K | 53.9Kdirect | Oct 6, 2025 | Oct 8, 2025 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −10.2K | $69.89 | $713K | 57.1Kdirect | Oct 6, 2025 | Oct 8, 2025 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −437 | $69.26 | $30K | 179.6Kdirect | Oct 6, 2025 | Oct 8, 2025 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −1,625 | $69.37 | $113K | 30.3Kdirect | Oct 6, 2025 | Oct 8, 2025 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −13.0K | $66.23 | $859K | 37.3Kdirect | Oct 2, 2025 | Oct 2, 2025 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −34.5K | $67.69 | $2.3M | 57.1Kdirect | Oct 2, 2025 | Oct 2, 2025 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −30.2K | $67.69 | $2.0M | 57.1Kdirect | Oct 2, 2025 | Oct 2, 2025 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −15.0K | $68.01 | $1.0M | 31.9Kdirect | Oct 2, 2025 | Oct 2, 2025 | Form 4 ↗ |
| WENDER JOSEPH HDirector | Sale | −16.8K | $65.50 | $1.1M | 92.0Kindirect | Oct 1, 2025 | Oct 2, 2025 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −14.1K | $66.09 | $935K | 37.3Kdirect | Oct 1, 2025 | Oct 2, 2025 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −14.8K | $64.68 | $959K | 57.1Kdirect | Sep 30, 2025 | Oct 1, 2025 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −57.9K | $65.24 | $3.8M | 79.7Kdirect | Sep 30, 2025 | Oct 1, 2025 | Form 4 ↗ |
| HOUGEN ELIZABETH LEVP, Finance & CFO | Sale | −49.8K | $65.26 | $3.2M | 110.5Kdirect | Sep 30, 2025 | Oct 1, 2025 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −10.5K | $64.54 | $676K | 57.1Kdirect | Sep 29, 2025 | Oct 1, 2025 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −1,700 | $64.58 | $110K | 57.1Kdirect | Sep 12, 2025 | Sep 16, 2025 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −11.9K | $62.16 | $743K | 31.9Kdirect | Sep 9, 2025 | Sep 11, 2025 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −1,000 | $64.56 | $65K | 57.1Kdirect | Sep 9, 2025 | Sep 11, 2025 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −20.0K | $64.56 | $1.3M | 57.1Kdirect | Sep 9, 2025 | Sep 11, 2025 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −250 | $62.00 | $16K | 31.9Kdirect | Sep 5, 2025 | Sep 9, 2025 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −6,000 | $59.60 | $358K | 82.7Kdirect | Sep 5, 2025 | Sep 9, 2025 | Form 4 ↗ |
| WENDER JOSEPH HDirector | Sale | −11.2K | $60.14 | $674K | 108.8Kindirect | Sep 3, 2025 | Sep 4, 2025 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −59.7K | $61.06 | $3.6M | 180.0Kdirect | Sep 3, 2025 | Sep 4, 2025 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −127.5K | $60.13 | $7.7M | 180.8Kdirect | Sep 3, 2025 | Sep 4, 2025 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −16.6K | $59.12 | $982K | 266.3Kdirect | Sep 3, 2025 | Sep 4, 2025 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −28.0K | $60.00 | $1.7M | 0indirect | Sep 3, 2025 | Sep 4, 2025 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −28.0K | $60.00 | $1.7M | 0indirect | Sep 3, 2025 | Sep 4, 2025 | Form 4 ↗ |
| Devers Shannon L.EVP, Chief Human Resources Ofc | Sale | −3,162 | $61.02 | $193K | 15.0Kdirect | Sep 3, 2025 | Sep 4, 2025 | Form 4 ↗ |
| WENDER JOSEPH HDirector | Sale | −11.2K | $60.14 | $674K | 108.8Kindirect | Sep 3, 2025 | Sep 4, 2025 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −30.0K | $59.09 | $1.8M | 16.9Kdirect | Sep 3, 2025 | Sep 4, 2025 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −2,800 | $62.01 | $174K | 31.9Kdirect | Sep 3, 2025 | Sep 4, 2025 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −11.4K | $61.42 | $699K | 7,330direct | Sep 3, 2025 | Sep 4, 2025 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −65.5K | $60.89 | $4.0M | 5,655direct | Sep 3, 2025 | Sep 4, 2025 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −33.9K | $60.62 | $2.1M | 101.6Kdirect | Sep 3, 2025 | Sep 4, 2025 | Form 4 ↗ |
| LOSCALZO JOSEPHDirector | Sale | −16.0K | $60.15 | $962K | 36.3Kdirect | Sep 3, 2025 | Sep 4, 2025 | Form 4 ↗ |
| Schneider EugeneEVP, Chf Clinical Develop Ofcr | Sale | −7,203 | $61.42 | $442K | 51.5Kdirect | Sep 3, 2025 | Sep 4, 2025 | Form 4 ↗ |
| Schneider EugeneEVP, Chf Clinical Develop Ofcr | Sale | −12.5K | $60.46 | $753K | 58.7Kdirect | Sep 3, 2025 | Sep 4, 2025 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −1,130 | $53.68 | $61K | 37.3Kdirect | Sep 2, 2025 | Sep 4, 2025 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −10.0K | $49.22 | $492K | 38.4Kdirect | Sep 2, 2025 | Sep 4, 2025 | Form 4 ↗ |
| WENDER JOSEPH HDirector | Sale | −5,600 | $57.53 | $322K | 120.0Kindirect | Sep 2, 2025 | Sep 4, 2025 | Form 4 ↗ |
| WENDER JOSEPH HDirector | Sale | −11.2K | $55.04 | $616K | 125.6Kindirect | Sep 2, 2025 | Sep 4, 2025 | Form 4 ↗ |
| PARSHALL B LYNNEDirector | Sale | −9,250 | $51.49 | $476K | 66.3Kdirect | Sep 2, 2025 | Sep 4, 2025 | Form 4 ↗ |
| PARSHALL B LYNNEDirector | Sale | −10.8K | $50.42 | $542K | 75.6Kdirect | Sep 2, 2025 | Sep 4, 2025 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −10.0K | $50.37 | $504K | 79.7Kdirect | Sep 2, 2025 | Sep 4, 2025 | Form 4 ↗ |
| WENDER JOSEPH HDirector | Sale | −5,600 | $57.53 | $322K | 120.0Kindirect | Sep 2, 2025 | Sep 4, 2025 | Form 4 ↗ |
| WENDER JOSEPH HDirector | Sale | −11.2K | $55.04 | $616K | 125.6Kindirect | Sep 2, 2025 | Sep 4, 2025 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −13.1K | $54.51 | $711K | 57.1Kdirect | Sep 2, 2025 | Sep 4, 2025 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −5,000 | $49.14 | $246K | 88.7Kdirect | Sep 2, 2025 | Sep 4, 2025 | Form 4 ↗ |
| Diaz Allene M.Director | Sale | −1,427 | $42.53 | $61K | 18.4Kdirect | Aug 22, 2025 | Aug 26, 2025 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −10.0K | $43.98 | $440K | 93.5Kdirect | Aug 18, 2025 | Aug 20, 2025 | Form 4 ↗ |
| PARSHALL B LYNNEDirector | Sale | −400 | $42.63 | $17K | 86.3Kdirect | Aug 6, 2025 | Aug 8, 2025 | Form 4 ↗ |
| PARSHALL B LYNNEDirector | Sale | −4,600 | $41.87 | $193K | 86.7Kdirect | Aug 6, 2025 | Aug 8, 2025 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −10.0K | $42.86 | $429K | 89.5Kdirect | Aug 5, 2025 | Aug 6, 2025 | Form 4 ↗ |
| Schneider EugeneEVP, Chf Clinical Develop Ofcr | Sale | −9,549 | $42.80 | $409K | 51.5Kdirect | Aug 4, 2025 | Aug 5, 2025 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −2,432 | $45.00 | $109K | 179.8Kdirect | Jul 30, 2025 | Aug 1, 2025 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −1,160 | $41.74 | $48K | 179.8Kdirect | Jul 11, 2025 | Jul 15, 2025 | Form 4 ↗ |
| Hayden Michael RDirector | Purchase | +15.0K | $31.86 | $478K | 50.2Kdirect | May 1, 2025 | May 2, 2025 | Form 4 ↗ |
| Birchler BrianEVP, Corp and Development Ops | Sale | −680 | $28.37 | $19K | 56.7Kdirect | Apr 16, 2025 | Apr 17, 2025 | Form 4 ↗ |
| Jenne KyleEVP, Chf GL Pdt Str Ofcr | Sale | −3,016 | $28.36 | $86K | 11.2Kdirect | Apr 16, 2025 | Apr 17, 2025 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −3,928 | $28.40 | $112K | 31.9Kdirect | Apr 16, 2025 | Apr 17, 2025 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −140 | $32.32 | $5K | 181.0Kdirect | Mar 11, 2025 | Mar 13, 2025 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −1,207 | $32.35 | $39K | 56.2Kdirect | Feb 20, 2025 | Feb 24, 2025 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −6,165 | $31.62 | $195K | 57.5Kdirect | Feb 4, 2025 | Feb 6, 2025 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −38.8K | $31.65 | $1.2M | 180.7Kdirect | Feb 4, 2025 | Feb 6, 2025 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −1,367 | $32.31 | $44K | 48.0Kdirect | Jan 31, 2025 | Feb 3, 2025 | Form 4 ↗ |
| Schneider EugeneEVP, Chf Clinical Develop Ofcr | Sale | −1,484 | $32.20 | $48K | 61.1Kdirect | Jan 31, 2025 | Feb 3, 2025 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −1,406 | $32.49 | $46K | 63.6Kdirect | Jan 31, 2025 | Feb 3, 2025 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −13.2K | $32.45 | $430K | 219.5Kdirect | Jan 31, 2025 | Feb 3, 2025 | Form 4 ↗ |
| HOUGEN ELIZABETH LEVP, Finance & CFO | Sale | −1,523 | $32.44 | $49K | 110.5Kdirect | Jan 31, 2025 | Feb 3, 2025 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −1,406 | $32.40 | $46K | 99.1Kdirect | Jan 31, 2025 | Feb 3, 2025 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −1,327 | $32.46 | $43K | 93.1Kdirect | Jan 31, 2025 | Feb 3, 2025 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −22 | $32.70 | $719 | 184indirect | Jan 16, 2025 | Jan 17, 2025 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −7,154 | $32.84 | $235K | 45.7Kdirect | Jan 16, 2025 | Jan 17, 2025 | Form 4 ↗ |
| Schneider EugeneEVP, Chf Clinical Develop Ofcr | Sale | −6,523 | $32.79 | $214K | 58.5Kdirect | Jan 16, 2025 | Jan 17, 2025 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −7,360 | $32.83 | $242K | 61.2Kdirect | Jan 16, 2025 | Jan 17, 2025 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −33.4K | $32.63 | $1.1M | 207.4Kdirect | Jan 16, 2025 | Jan 17, 2025 | Form 4 ↗ |
| HOUGEN ELIZABETH LEVP, Finance & CFO | Sale | −8,870 | $32.81 | $291K | 107.9Kdirect | Jan 16, 2025 | Jan 17, 2025 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −7,072 | $32.86 | $232K | 96.7Kdirect | Jan 16, 2025 | Jan 17, 2025 | Form 4 ↗ |
| Devers Shannon L.EVP, Chief Human Resources Ofc | Sale | −4,267 | $32.78 | $140K | 15.9Kdirect | Jan 16, 2025 | Jan 17, 2025 | Form 4 ↗ |
| Birchler BrianEVP, Corp and Development Ops | Sale | −5,400 | $32.70 | $177K | 55.1Kdirect | Jan 16, 2025 | Jan 17, 2025 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −6,752 | $32.90 | $222K | 90.9Kdirect | Jan 16, 2025 | Jan 17, 2025 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −1,029 | $32.70 | $34K | 3,071indirect | Jan 16, 2025 | Jan 17, 2025 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −3,401 | $32.70 | $111K | 25.0Kdirect | Jan 16, 2025 | Jan 17, 2025 | Form 4 ↗ |
| Hayden Michael RDirector | Purchase | +2,500 | $36.23 | $91K | 35.2Kdirect | Dec 23, 2024 | Dec 26, 2024 | Form 4 ↗ |
| Hayden Michael RDirector | Purchase | +2,500 | $36.20 | $91K | 32.7Kdirect | Dec 23, 2024 | Dec 26, 2024 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −1,194 | $37.92 | $45K | 33.7Kdirect | Nov 12, 2024 | Nov 14, 2024 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −6,630 | $38.05 | $252K | 167.4Kdirect | Nov 12, 2024 | Nov 14, 2024 | Form 4 ↗ |
| LOSCALZO JOSEPHDirector | Sale | −13.5K | $37.86 | $511K | 32.3Kdirect | Nov 12, 2024 | Nov 14, 2024 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −53 | $38.31 | $2K | 157indirect | Oct 16, 2024 | Oct 17, 2024 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −331 | $49.63 | $16K | 84.8Kdirect | Aug 29, 2024 | Sep 3, 2024 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −320 | $49.16 | $16K | 85.2Kdirect | Aug 28, 2024 | Sep 3, 2024 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −2,430 | $48.00 | $117K | 85.5Kdirect | Aug 5, 2024 | Aug 6, 2024 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −12.0K | $50.00 | $600K | 0indirect | Jul 16, 2024 | Jul 17, 2024 | Form 4 ↗ |
| Diaz Allene M.Director | Sale | −737 | $50.17 | $37K | 15.7Kdirect | Jul 16, 2024 | Jul 17, 2024 | Form 4 ↗ |
| Diaz Allene M.Director | Sale | −900 | $48.94 | $44K | 16.5Kdirect | Jul 16, 2024 | Jul 17, 2024 | Form 4 ↗ |
| BERTHELSEN SPENCER RDirector | Sale | −16.0K | $40.29 | $645K | 147.3Kdirect | Jun 17, 2024 | Jun 20, 2024 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −930 | $42.90 | $40K | 0indirect | May 3, 2024 | May 7, 2024 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −1,070 | $42.55 | $46K | 930indirect | May 3, 2024 | May 7, 2024 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −731 | $42.98 | $31K | 2,000indirect | May 3, 2024 | May 7, 2024 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −1,269 | $42.59 | $54K | 2,731indirect | May 3, 2024 | May 7, 2024 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −682 | $42.94 | $29K | 4,000indirect | May 3, 2024 | May 7, 2024 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −1,318 | $42.57 | $56K | 4,682indirect | May 3, 2024 | May 7, 2024 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −4,006 | $41.60 | $167K | 19.6Kdirect | Apr 16, 2024 | Apr 17, 2024 | Form 4 ↗ |
| Birchler BrianEVP, Corp and Development Ops | Sale | −905 | $41.66 | $38K | 46.2Kdirect | Apr 16, 2024 | Apr 17, 2024 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −387 | $44.49 | $17K | 173.8Kdirect | Feb 16, 2024 | Feb 16, 2024 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale Amended | −1,995 | $50.04 | $100K | 87.3Kdirect | Feb 2, 2024 | Sep 4, 2024 | Form 4 ↗ |
| HOUGEN ELIZABETH LEVP, Finance & CFO | Sale Amended | −2,162 | $49.54 | $107K | 92.9Kdirect | Feb 2, 2024 | Sep 4, 2024 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale Amended | −1,995 | $49.67 | $99K | 48.6Kdirect | Feb 2, 2024 | Sep 4, 2024 | Form 4 ↗ |
| Schneider EugeneEVP, Chf Clinical Develop Ofcr | Sale Amended | −2,106 | $49.59 | $104K | 47.7Kdirect | Feb 2, 2024 | Sep 4, 2024 | Form 4 ↗ |
| Swayze EricEVP Research | Sale Amended | −1,940 | $49.56 | $96K | 34.3Kdirect | Feb 2, 2024 | Sep 4, 2024 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale Amended | −23.9K | $49.37 | $1.2M | 173.7Kdirect | Feb 2, 2024 | Sep 4, 2024 | Form 4 ↗ |
| Cadoret-Manier OnaizaEVP,Chf GL Pdt Str & Oper Ofc | Sale Amended | −2,162 | $49.60 | $107K | 35.8Kdirect | Feb 2, 2024 | Sep 4, 2024 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale Amended | −1,885 | $49.52 | $93K | 79.0Kdirect | Feb 2, 2024 | Sep 4, 2024 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale Amended | −23.9K | $49.37 | $1.2M | 173.7Kdirect | Feb 2, 2024 | Sep 4, 2024 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −1,907 | $49.56 | $95K | 34.3Kdirect | Feb 2, 2024 | Feb 2, 2024 | Form 4 ↗ |
| Schneider EugeneEVP, Chf Clinical Develop Ofcr | Sale | −2,071 | $49.59 | $103K | 49.8Kdirect | Feb 2, 2024 | Feb 2, 2024 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −1,961 | $49.67 | $97K | 48.7Kdirect | Feb 2, 2024 | Feb 2, 2024 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −23.5K | $49.37 | $1.2M | 174.1Kdirect | Feb 2, 2024 | Feb 2, 2024 | Form 4 ↗ |
| HOUGEN ELIZABETH LEVP, Finance & CFO | Sale | −2,125 | $49.54 | $105K | 92.9Kdirect | Feb 2, 2024 | Feb 2, 2024 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −1,961 | $50.04 | $98K | 87.3Kdirect | Feb 2, 2024 | Feb 2, 2024 | Form 4 ↗ |
| Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper Ofc | Sale | −2,125 | $49.60 | $105K | 35.8Kdirect | Feb 2, 2024 | Feb 2, 2024 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −1,853 | $49.52 | $92K | 79.1Kdirect | Feb 2, 2024 | Feb 2, 2024 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −10.8K | $52.00 | $560K | 32.5Kdirect | Jan 31, 2024 | Feb 2, 2024 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −2,285 | $51.75 | $118K | 151.9Kdirect | Jan 25, 2024 | Jan 29, 2024 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −6,450 | $51.75 | $334K | 46.8Kdirect | Jan 25, 2024 | Jan 29, 2024 | Form 4 ↗ |
| Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper Ofc | Sale | −5,564 | $50.42 | $281K | 33.8Kdirect | Jan 17, 2024 | Jan 18, 2024 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −7,744 | $50.42 | $390K | 53.3Kdirect | Jan 17, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Birchler BrianEVP, Corp and Development Ops | Sale | −4,497 | $50.42 | $227K | 44.6Kdirect | Jan 17, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −9 | $50.42 | $454 | 85indirect | Jan 17, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −6,296 | $50.42 | $317K | 43.3Kdirect | Jan 17, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Schneider EugeneEVP, Chf Clinical Develop Ofcr | Sale | −5,482 | $50.42 | $276K | 47.9Kdirect | Jan 17, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −32.1K | $50.42 | $1.6M | 154.1Kdirect | Jan 17, 2024 | Jan 18, 2024 | Form 4 ↗ |
| HOUGEN ELIZABETH LEVP, Finance & CFO | Sale | −8,683 | $50.42 | $438K | 90.9Kdirect | Jan 17, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −7,338 | $50.42 | $370K | 85.5Kdirect | Jan 17, 2024 | Jan 18, 2024 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −6,745 | $50.42 | $340K | 77.3Kdirect | Jan 17, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −564 | $50.42 | $28K | 1,640indirect | Jan 17, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Baroldi JosephEVP, Chief Business Officer | Sale | −1,460 | $50.42 | $74K | 12.8Kdirect | Jan 17, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Schneider EugeneEVP, Chf Clinical Develop Ofcr | Sale | −8,000 | $53.50 | $428K | 38.2Kdirect | Jan 12, 2024 | Jan 17, 2024 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −27.1K | $50.19 | $1.4M | 32.5Kdirect | Dec 28, 2023 | Jan 2, 2024 | Form 4 ↗ |
| PARSHALL B LYNNEDirector | Sale | −42.5K | $50.19 | $2.1M | 82.6Kdirect | Dec 28, 2023 | Dec 28, 2023 | Form 4 ↗ |
| PARSHALL B LYNNEDirector | Sale | −50.0K | $50.23 | $2.5M | 82.6Kdirect | Dec 27, 2023 | Dec 28, 2023 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −20.8K | $51.46 | $1.1M | 40.4Kdirect | Dec 26, 2023 | Dec 28, 2023 | Form 4 ↗ |
| PARSHALL B LYNNEDirector | Sale | −25.1K | $51.46 | $1.3M | 82.6Kdirect | Dec 26, 2023 | Dec 28, 2023 | Form 4 ↗ |
| Schneider EugeneEVP, Chf Clinical Develop Ofcr | Sale | −25.0K | $51.46 | $1.3M | 36.1Kdirect | Dec 26, 2023 | Dec 28, 2023 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −16.1K | $49.29 | $794K | 65.8Kdirect | Dec 21, 2023 | Dec 22, 2023 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −4,112 | $49.29 | $203K | 73.0Kdirect | Dec 21, 2023 | Dec 22, 2023 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −17.5K | $49.29 | $863K | 118.1Kdirect | Dec 21, 2023 | Dec 22, 2023 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −6,500 | $49.64 | $323K | 65.8Kdirect | Dec 20, 2023 | Dec 22, 2023 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −6,500 | $49.64 | $323K | 73.0Kdirect | Dec 20, 2023 | Dec 22, 2023 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −6,500 | $49.64 | $323K | 118.1Kdirect | Dec 20, 2023 | Dec 22, 2023 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −9,140 | $50.19 | $459K | 118.1Kdirect | Dec 14, 2023 | Dec 18, 2023 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −14.9K | $49.21 | $731K | 118.1Kdirect | Dec 14, 2023 | Dec 18, 2023 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −4,042 | $50.19 | $203K | 73.0Kdirect | Dec 14, 2023 | Dec 18, 2023 | Form 4 ↗ |
| Geary Richard SEVP, Chief Development Officer | Sale | −6,571 | $49.21 | $323K | 73.0Kdirect | Dec 14, 2023 | Dec 18, 2023 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −8,610 | $50.19 | $432K | 65.8Kdirect | Dec 14, 2023 | Dec 18, 2023 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −14.0K | $49.21 | $689K | 65.8Kdirect | Dec 14, 2023 | Dec 18, 2023 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −2,000 | $50.00 | $100K | 16.3Kdirect | Nov 15, 2023 | Nov 17, 2023 | Form 4 ↗ |
| Swayze EricEVP Research | Sale | −52 | $47.95 | $2K | 73indirect | Oct 17, 2023 | Oct 18, 2023 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −3,770 | $46.00 | $173K | 118.1Kdirect | Oct 12, 2023 | Oct 16, 2023 | Form 4 ↗ |
| BENNETT C FRANKEVP, Chief Scientific Officer | Sale | −4,460 | $46.50 | $207K | 65.8Kdirect | Sep 28, 2023 | Sep 29, 2023 | Form 4 ↗ |
| PARSHALL B LYNNEDirector | Sale | −10.0K | $45.13 | $451K | 82.6Kdirect | Sep 26, 2023 | Sep 28, 2023 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −2,000 | $45.13 | $90K | 18.3Kdirect | Sep 26, 2023 | Sep 28, 2023 | Form 4 ↗ |
| Diaz Allene M.Director | Sale | −657 | $41.05 | $27K | 12.7Kdirect | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| KLEIN JOSEPH IIIDirector | Sale | −3,555 | $42.00 | $149K | 20.3Kdirect | Jul 18, 2023 | Jul 19, 2023 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −18.6K | $42.25 | $788K | 121.7Kdirect | Jul 7, 2023 | Jul 11, 2023 | Form 4 ↗ |
| O'NEIL PATRICK R.EVP CLO & General Counsel | Sale | −1,527 | $41.70 | $64K | 40.4Kdirect | May 24, 2023 | May 24, 2023 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −2,630 | $40.14 | $106K | 140.4Kdirect | May 22, 2023 | May 24, 2023 | Form 4 ↗ |
| Monia Brett PChief Executive Officer · Director | Sale | −2,301 | $40.13 | $92K | 143.0Kdirect | May 22, 2023 | May 24, 2023 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →